Open AccessThe HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
Author(s) -
Paolo Giani,
Daniela de Totero
Publication year - 2021
Language(s) - English
DOI - 10.20517/cdr.2021.73
Subject(s) - hepatocyte growth factor , multiple myeloma , autocrine signalling , c met , paracrine signalling , cancer research , medicine , bone marrow , disease , chemotherapy , immunology , receptor